39000270|t|Addition of Polyphenols to Drugs: The Potential of Controlling "Inflammaging" and Fibrosis in Human Senescent Lung Fibroblasts In Vitro.
39000270|a|The combination of a polyphenol, quercetin, with dasatinib initiated clinical trials to evaluate the safety and efficacy of senolytics in idiopathic pulmonary fibrosis, a lung disease associated with the presence of senescent cells. Another approach to senotherapeutics consists of controlling inflammation related to cellular senescence or "inflammaging", which participates, among other processes, in establishing pulmonary fibrosis. We evaluate whether polyphenols such as caffeic acid, chlorogenic acid, epicatechin, gallic acid, quercetin, or resveratrol combined with different senotherapeutics such as metformin or rapamycin, and antifibrotic drugs such as nintedanib or pirfenidone, could present beneficial actions in an in vitro model of senescent MRC-5 lung fibroblasts. A senescent-associated secretory phenotype (SASP) was evaluated by the measurement of interleukin (IL)-6, IL-8, and IL-1beta. The senescent-associated beta-galactosidase (SA-beta-gal) activity and cellular proliferation were assessed. Fibrosis was evaluated using a Picrosirius red assay and the gene expression of fibrosis-related genes. Epithelial-mesenchymal transition (EMT) was assayed in the A549 cell line exposed to Transforming Growth Factor (TGF)-beta in vitro. The combination that demonstrated the best results was metformin and caffeic acid, by inhibiting IL-6 and IL-8 in senescent MRC-5 cells. Metformin and caffeic acid also restore cellular proliferation and reduce SA-beta-gal activity during senescence induction. The collagen production by senescent MRC-5 cells was inhibited by epicatechin alone or combined with drugs. Epicatechin and nintedanib were able to control EMT in A549 cells. In conclusion, caffeic acid and epicatechin can potentially increase the effectiveness of senotherapeutic drugs in controlling lung diseases whose pathophysiological component is the presence of senescent cells and fibrosis.
39000270	12	23	Polyphenols	Chemical	MESH:D059808
39000270	82	90	Fibrosis	Disease	MESH:D005355
39000270	94	99	Human	Species	9606
39000270	158	168	polyphenol	Chemical	MESH:D059808
39000270	170	179	quercetin	Chemical	MESH:D011794
39000270	186	195	dasatinib	Chemical	MESH:D000069439
39000270	275	304	idiopathic pulmonary fibrosis	Disease	MESH:D054990
39000270	308	320	lung disease	Disease	MESH:D008171
39000270	431	443	inflammation	Disease	MESH:D007249
39000270	553	571	pulmonary fibrosis	Disease	MESH:D011658
39000270	593	604	polyphenols	Chemical	MESH:D059808
39000270	613	625	caffeic acid	Chemical	MESH:C040048
39000270	627	643	chlorogenic acid	Chemical	MESH:D002726
39000270	645	656	epicatechin	Chemical	MESH:D002392
39000270	658	669	gallic acid	Chemical	MESH:D005707
39000270	671	680	quercetin	Chemical	MESH:D011794
39000270	685	696	resveratrol	Chemical	MESH:D000077185
39000270	746	755	metformin	Chemical	MESH:D008687
39000270	759	768	rapamycin	Chemical	MESH:D020123
39000270	801	811	nintedanib	Chemical	MESH:C530716
39000270	815	826	pirfenidone	Chemical	MESH:C093844
39000270	895	900	MRC-5	CellLine	CVCL:0440
39000270	1025	1029	IL-8	Gene	3576
39000270	1035	1043	IL-1beta	Gene	3553
39000270	1090	1092	SA	Chemical	MESH:D000077145
39000270	1154	1162	Fibrosis	Disease	MESH:D005355
39000270	1185	1200	Picrosirius red	Chemical	MESH:C009798
39000270	1234	1242	fibrosis	Disease	MESH:D005355
39000270	1317	1321	A549	CellLine	CVCL:0023
39000270	1446	1455	metformin	Chemical	MESH:D008687
39000270	1460	1472	caffeic acid	Chemical	MESH:C040048
39000270	1488	1492	IL-6	Gene	3569
39000270	1497	1501	IL-8	Gene	3576
39000270	1515	1520	MRC-5	CellLine	CVCL:0440
39000270	1528	1537	Metformin	Chemical	MESH:D008687
39000270	1542	1554	caffeic acid	Chemical	MESH:C040048
39000270	1602	1604	SA	Chemical	MESH:D000077145
39000270	1689	1694	MRC-5	CellLine	CVCL:0440
39000270	1718	1729	epicatechin	Chemical	MESH:D002392
39000270	1760	1771	Epicatechin	Chemical	MESH:D002392
39000270	1776	1786	nintedanib	Chemical	MESH:C530716
39000270	1815	1819	A549	CellLine	CVCL:0023
39000270	1842	1854	caffeic acid	Chemical	MESH:C040048
39000270	1859	1870	epicatechin	Chemical	MESH:D002392
39000270	1954	1967	lung diseases	Disease	MESH:D008171
39000270	2042	2050	fibrosis	Disease	MESH:D005355
39000270	Cotreatment	MESH:C040048	MESH:D008687
39000270	Negative_Correlation	MESH:D002392	MESH:D005355
39000270	Negative_Correlation	MESH:D002392	MESH:D008171
39000270	Negative_Correlation	MESH:C040048	MESH:D000077145
39000270	Negative_Correlation	MESH:D000069439	MESH:D011794
39000270	Negative_Correlation	MESH:D008687	3576
39000270	Negative_Correlation	MESH:D000077145	MESH:D008687
39000270	Negative_Correlation	MESH:C040048	MESH:D005355
39000270	Negative_Correlation	MESH:C040048	3569
39000270	Negative_Correlation	MESH:D008687	3569
39000270	Negative_Correlation	MESH:D000069439	MESH:D054990
39000270	Negative_Correlation	MESH:C040048	3576
39000270	Negative_Correlation	MESH:C040048	MESH:D008171

